Back

Matisse Study: A Pilot Study in Metastatic Advanced Thyroid Cancer Evaluating the Safety & Efficacy of Sorafenib (UK Drug Trial)

We have the following news regarding this trial:

The Royal Marsden Hospital in London is recruiting for a trial for thyroid cancer patients (including MTC) of a drug called Sorafenib.  They have currently only recruited from RMH, but will also accept patients from outside their area, however they are not in a position to fund travel expenses.  This is a pilot trial, which, if successful, will be taken nationally.

 If you are in any way interested in this trial, please ask your specialist to contact:

Dr Christopher Nutting

Head of Head and Neck Unit
Royal Marsden NHS Trust
Fulham Road
Chelsea
London
SW3 6JJ
England

Telephone: 020 7352 8171   Fax: 020 7808 2048

E-mail: Chris.Nutting@rmh.nhs.uk